drugset / Trial / NCT02653560

Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension

NCT02653560

Phase 4 Completed 30 enrolled University of Texas Southwestern Medical Center
RandomizedCrossoverDouble-blindTreatment

Summary

In the DASH (Dietary Approaches to Stop Hypertension) trials, a diet rich in fruits, vegetables, nuts and dairy products, and limited in fat content, was shown to be useful in controlling hypertension. Key components of such a diet are potassium, magnesium and alkali, each of which has been implicated in lowering blood pressure. Whether a liquid formulation of potassium-magnesium citrate will result in equivalent BP effect as the DASH diet is unknown.

Timeline

Start
2012-09
Primary completion
2015-01
Completion
2015-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject POTASSIUM CITRATE ANHYDROUS Small molecule 40 meq Oral
Subject POTASSIUM MAGNESIUM CITRATE (4:1:2) Small molecule 20 meq Oral
Subject POTASSIUM MAGNESIUM CITRATE (4:1:2) Small molecule 40 meq Oral
Subject POTASSIUM MAGNESIUM CITRATE (4:1:2) Small molecule 74 meq Oral
Subject Potassium Chloride Small molecule 40 meq Oral

Indications